A prospective study to monitor the side effects associated with disease modifying anti rheumatoid drugs in out-patients of tertiary care hospital. Int. J. of Res. in Pharmacology &Pharmacotherapeutics [Internet]. 2023 Feb. 19 [cited 2026 Apr. 18];12(1):1-7. Available from: https://ijrpp.com/ijrpp/article/view/459